Prot #STU00215064: NU 20H09: Phase II, Single-arm, Open-label, Multicenter Study Evaluating the Efficacy of Adjunctive Zanubrutinib and CAR T-cell Therapy in Aggressive B-cell Non-Hodgkin's Lymphoma

Project: Research project

Project Details

StatusActive
Effective start/end date12/21/21 → 12/21/27

Funding

  • BeiGene Switzerland GmbH ((OE) Prot #STU00215064)